Zhu T, Wang L, Jiang H, Huang S, et al. Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study. Ann Hematol 2025 May 20. doi: 10.1007/s00277-025-06389.
PMID: 40389725